ストックスクリーナーアプリを入手
6.49
7.14%
-0.40
アフターアワーズ：
6.48
-0.010
-0.15%
前日終値:
$6.89
開ける：
$6.8
24時間の取引高:
556.76K
Relative Volume:
0.51
時価総額：
$269.94M
収益：
$134.48M
当期純損益:
$-38.94M
株価収益率:
-6.8072
EPS:
-0.9534
ネットキャッシュフロー:
$-19.34M
1週間 パフォーマンス:
-2.62%
1か月 パフォーマンス:
+15.28%
6か月 パフォーマンス:
-25.69%
1年 パフォーマンス:
-24.10%
1日の値動き範囲:
$6.385
$6.87
1週間の範囲:
$6.385
$7.22
52週間の値動き範囲:
$4.48
$13.22
Rxsight Inc Stock (RXST) Company Profile
Compare RXST vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
6.49 | 286.58M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
110.36 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.66 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.60 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.45 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.81 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | 開始されました | William Blair | Mkt Perform |
| 2025-07-15 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | ダウングレード | Jefferies | Buy → Hold |
| 2025-07-09 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-09 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-07-09 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | 開始されました | Piper Sandler | Neutral |
| 2025-04-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-04-04 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2025-04-03 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-12-20 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | UBS | Buy |
| 2024-10-29 | 開始されました | Jefferies | Buy |
| 2024-08-20 | 繰り返されました | Needham | Buy |
| 2024-08-06 | 繰り返されました | Needham | Buy |
| 2024-05-07 | 繰り返されました | BTIG Research | Buy |
| 2023-12-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 開始されました | Stifel | Buy |
| 2023-12-04 | 開始されました | Morgan Stanley | Overweight |
| 2023-04-13 | 開始されました | Oppenheimer | Outperform |
| 2022-12-12 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 開始されました | Needham | Buy |
すべてを表示
Rxsight Inc (RXST) 最新ニュース
Walleye Capital LLC Takes Position in RxSight, Inc. $RXST - marketbeat.com
Midday Stock Roundup: Staar Surgical Dips 8% After Analyst Price Cut - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - marketbeat.com
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? - Yahoo Finance
RxSight (RXST) Q2 2026 Earnings Call Transcript - AOL.com
(RXST) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development - AOL.com
Rxsight Inc (RXST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments - VisionMonday.com
Eye care company Alcon raises margin outlook, shares jump - marketscreener.com
Stifel cuts RxSight stock price target on competitive headwinds By Investing.com - Investing.com India
RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges - streetinsider.com
Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $7.00 - marketbeat.com
Stifel cuts RxSight stock price target on competitive headwinds - Investing.com
RxSight (RXST) offers to swap 4.08M underwater options for new awards - Stock Titan
Stifel Maintains RxSight(RXST.US) With Hold Rating, Cuts Target Price to $7 - Moomoo
RxSight Reports Q2 Financial Results, Provides Update on 2026 Outlook - VisionMonday.com
The RxSight, Inc. (NASDAQ:RXST) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
Wall Street Zen Upgrades RxSight (NASDAQ:RXST) to Hold - MarketBeat
Levi & Korsinsky Notifies RxSight, Inc. (RXST) InvestorsLead Plaintiff Deadline on September 22, 2025 - The National Law Review
Rxsight Inc (RXST) Stock News Today - TradingKey
A Quick Look at Today's Ratings for RxSight(RXST.US), With a Forecast Between $6 to $11 - moomoo.com
RXST|Rxsight Inc|Price:6.260|Chg%:+0.180 - TradingKey
UBS Maintains RxSight(RXST.US) With Hold Rating, Cuts Target Price to $6.3 - Moomoo
UBS Group Boosts RxSight (NASDAQ:RXST) Price Target to $6.30 - MarketBeat
Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 5 - GuruFocus
Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 519% Upside - Yahoo Finance
RxSight, Inc. Stock 12‑Month Price Target Cut to $7.91, Implies 26% Upside - TradingView
A Quick Look at Today's Ratings for RxSight(RXST.US), With a Forecast Between $9 to $11 - moomoo.com
Rxsight, Inc. Reports Second Quarter 2026 Res - Moomoo
RxSight Q2 Earnings Call Highlights - MarketBeat
RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ... - finance.yahoo.com
RxSight (NASDAQ:RXST) Releases Earnings Results, Beats Estimates By $0.22 EPS - MarketBeat
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates - finance.yahoo.com
RxSight, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
RXST: Q2 revenue was $33.7M, guidance withdrawn as business undergoes strategic reassessment - TradingView
Earnings call transcript: RxSight beats Q2 2026 estimates but withdraws guidance - Investing.com
Transcript : RxSight, Inc., Q2 2026 Earnings Call, Aug 05, 2026 - marketscreener.com
RxSight Q2 adjusted loss beats estimates; withdraws 2026 guidance - TradingView
RxSight (RXST) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
RxSight, Inc. (RXST) Tops Q2 EPS by 25c - StreetInsider
RxSight, Inc. Q2 2026: Revenue $33.74M, EPS $(0.29) — 10-Q Summary - TradingView
RxSight (NASDAQ: RXST) reports $33.7M Q2 revenue and $60M Alcon collaboration - Stock Titan
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook - The Manila Times
RXSIGHT INC Q2 ADJUSTED EPS USD -0.11 VS. IBES ESTIMATE USD -0.33 - moomoo.com
RxSight (RXST): Millennium entities, Israel Englander report 7.3% ownership stake - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
RxSight, Inc. expected to post a loss of 33 cents a shareEarnings Preview - TradingView
(RXST) Risk Channels and Responsive Allocation - Stock Traders Daily
Rxsight Inc (RXST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rxsight Inc (RXST) 財務データ
収益
当期純利益
現金流量
EPS
Rxsight Inc (RXST) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Goldshleger Ilya | See remarks |
Sep 25 '25 |
Option Exercise |
4.27 |
23,445 |
99,998 |
65,691 |
2.43%
大文字化:
|
ボリューム (24 時間):